These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20089096)

  • 1. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
    Baillargeon-Gagné S; Jeldres C; Lughezzani G; Sun M; Isbarn H; Capitanio U; Shariat SF; Crépel M; Alasker A; Widmer H; Arjane P; Patard JJ; Perrotte P; Montorsi F; Graefen M; Karakiewicz PI
    BJU Int; 2010 Feb; 105(3):359-64. PubMed ID: 20089096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment management of small renal masses in the 21st century: a paradigm shift.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
    Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal surgery for cortical neoplasms on lipid metabolism.
    Bagrodia A; Kopp RP; Mehrazin R; Lee HJ; Liss MA; Jabaji R; Kane CJ; Wake RW; Patterson AL; Wan JY; Derweesh IH
    BJU Int; 2014 Dec; 114(6):837-43. PubMed ID: 24656182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term renal function in patients with renal-cell carcinoma treated surgically: comparison between radical and partial nephrectomy].
    López-Garibay LA; Cendejas-Gómez Jde J; Rodríguez-Covarrubias F; Gómez-Conzatti A; Gabilondo-Navarro F; Sotomayor-de-Zavaleta M
    Rev Invest Clin; 2013; 65(1):7-11. PubMed ID: 23745439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
    Jeldres C; Bensalah K; Capitanio U; Zini L; Perrotte P; Suardi N; Tostain J; Valeri A; Descotes JL; Rambeaud JJ; de La Taille A; Salomon L; Abbou C; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Jun; 103(12):1632-5. PubMed ID: 19545272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
    Vricella GJ; Finelli A; Alibhai SM; Ponsky LE; Abouassaly R
    BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
    BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
    Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
    Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
    Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
    Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.